15-Oct-15 Japan's drug regulator, the Pharmaceuticals and Medical Devices Agency (PMDA), is set to open an India office soon. The move is expected to help Indian generic drug manufacturers, which have been seeking to increase their presence in Japan either through exports or by forging joint ventures with partners in that country. [image: The Economic Times]

15-Oct-15 Vetter, a global leader in aseptic manufacturing of drug-delivery systems, has announced a new business entity in Japan. As the second largest pharmaceutical single market, Japan is home to a number of leading global companies which offer a promising injectable pipeline. [image: Business Wire]

14-Oct-15 Indian drug retailers shut up shop for the day on Wednesday to protest against the country's growing online pharmacy industry, and threatened to close indefinitely if the government did not shut down e-pharmacies. The nationwide protest was supported by as many as 850,000 chemists, leaving patients waiting in long queues. [image: Reuters]

10-Oct-15 Myanmar is trying to kick its foreign drug habit: In recent years the government has offered incentives to seven private distributors to try their hand at manufacturing domestically. All other pharmaceutical products – between 80 percent and 90 percent – are imported. [image: Ann Wang / Frontier Myanmar]

09-Oct-15 Many treatments, including Herceptin and Gilead Sciences’ Sovaldi for hepatitis C, are either unavailable or more expensive in China than elsewhere. Aside from the lower price, visitors to Hong Kong from the mainland also prefer to buy their medicine there because they believe it is less likely to be counterfeit. [image: Bloomberg Business]